Lidocaine transdermal patch (Teikoku Pharma Usa)

利多卡因凝胶贴膏 (Teikoku Pharma Usa)

Report date: 2026/03/10 20:00:16

Base Information

Drug NameLidocaine transdermal patch (Teikoku Pharma Usa)
Drug Alias NameVersatisLidoderm
ClassificationSmall molecules
Mechanisms of ActionSodium channel alpha subunit modulators
TargetsSodium channel alpha subunit
Therapy Area/IndicationsPainNeuralgia, PostherpeticHerpes Zoster
Global Approved IndicationsNeuralgia, Postherpetic
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1999/03/19
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesTeikoku Pharma Usa Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsPainNeuralgia, PostherpeticHerpes Zoster
Inactive IndicationsN/A

Other Information

ATC CodeN/A